Ann Dermatol.  1991 Jul;3(2):107-111. 10.5021/ad.1991.3.2.107.

Treatment of Erythrodermic Psoriasis with Etretinate

Abstract

We have investigated the clinical response of 12 patients with erythrodermic psoriasis to therapy with etretinate. Initial dosage of etretinate was 20-60mg/day. The time for complete disappearance of scales averaged 19.9 days. In 10 of 12 patients(83.3%) satisfactory results were obtained after 2 to 11 months of treatment. Cheilitis was the most common side effect. Three patients had mild elevation of blood lipids, which was corrected by dose reduction. Remission period, of ten patients who showed good result, averaged 4.2 months.

Keyword

Erythrodermic psoriasis; Etretinate

MeSH Terms

Acitretin*
Cheilitis
Etretinate*
Humans
Psoriasis*
Weights and Measures
Acitretin
Etretinate
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr